Document is current
Any future updates will be listed below
-
Authors
Samson, Andre L. https://orcid.org/0000-0002-0637-2716
Murphy, James M. https://orcid.org/0000-0003-0195-3949
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1172929)
Department of Health | National Health and Medical Research Council (9000719)
Department of Health | National Health and Medical Research Council (2002965)
- License Information
-
More Information
Article History
Received: 14 May 2024
Revised: 23 May 2024
Accepted: 24 May 2024
First Online: 4 June 2024
Competing interests
: ALS and JMM have contributed to the development of necroptosis pathway inhibitors in collaboration with Anaxis Pharma Pty Ltd. JMM has received research funding from Anaxis Pharma Pty Ltd.
